INTS CIK: 1567264

Intensity Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
1.45
FY23:
15.5
FY24:
3.36
FY25:
12.7
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.31
FY23:
1.83
FY24:
1.42
FY25:
1.39
Total assets
Change from FY22 to FY25
millions USD
FY22:
1.76
FY23:
17.3
FY24:
4.78
FY25:
14.1

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
6.82
FY23:
3.96
FY24:
1.76
FY25:
2.15
(negative)
Change from FY22 to FY25
millions USD
FY22:
0.04
FY23:
0.17
FY24:
0.11
FY25:
0.08
(positive)
Change from FY22 to FY25
millions USD
FY22:
−15.1
FY23:
13.2
FY24:
2.92
FY25:
11.9
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
17.3
FY24:
4.78
FY25:
14.1

All amounts in millions USD Data source:SEC EDGAR